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re-intervention at 5 years (7% vs. 15%); complexity of follow-up (with vs. without 
CT examination); risk of major complications (2% vs. 5%); additional cost of inter-
vention (c0 vs. c2000). Patients preferences were elicited before treatment (NAIF) and 
after treatment with open surgery (OPEN) or endovascular procedure (EVAR). a 
segmentation conditional logistic regression model was applied to estimate relative 
importance (RI) assigned to each characteristic according to patients’ experience with 
treatment. RESULTS: A total of 160 patients participated (aged 49–88 years, 91.7% 
male) from 9 hospitals. Fifty-two percent were NAIF at enrolment. Overall, half 
patients were treated with OPEN, half with EVAR. One most important characteristic, 
risk of procedural major complications, was considered more important by NAIF and 
EVAR than OPEN (RI = 31.7% and 22.0% vs. 11.0%). Additional costs were more 
important to OPEN (RI = 38.3%) than NAIF (25.2%) and EVAR (19.5%). Local 
anaesthesia was more important to EVAR (24.8%) than NAIF or OPEN (RI = 8.5%). 
Risk of repeating the procedure was similarly important to treated patients (RI = 
17.5%), less to NAIF (RI = 12.3%). Recovery time was more important to OPEN (RI 
= 14.3%) and EVAR (RI = 10.3%) than NAIF (8.6%). Type of follow-up tests was 
least important, with OPEN and NAIF preferring less complex tests (RI = 4–10%), 
but EVAR preferring more complex tests (RI = 6%). CONCLUSIONS: Preferences 
depend on experience, knowledge and expectancies. Understanding patients’ prefer-
ences can help physicians to optimize beneﬁ ts of treatments.
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OBJECTIVES: Individuals with type 2 diabetes mellitus (T2DM) are known to have 
poorer quality of life and more depressive symptoms than those without diabetes, yet 
the impact may be in part due to comorbid conditions. This study compared quality of 
life and depression among adults with T2DM and comorbid hypertension (HTN) and 
obesity with adults reporting T2DM only. METHODS: Respondents to the Study to 
Help Improve Early evaluation and management of risk factors Leading to Diabetes 
(SHIELD), a large US survey, self-reported their height, weight, and comorbid condi-
tions, and completed the Short Form- 12 (SF-12) and Patient Health Questionnaire 
(PHQ-9, depression assessment). Respondents reporting T2DM and HTN and obesity 
(body mass index [BMI] ≥30 kg/m2) were identiﬁ ed and compared with a T2DM-only 
group. RESULTS: Respondents with T2DM and comorbid HTN and obesity (n = 1292) 
were similar to T2DM-only respondents (n = 349) in race, education, smoking, and 
cardiovascular disease history (all p > 0.05), but were younger and were more likely to 
be men and have lower income (P < 0.01). Respondents with T2DM, HTN and obesity 
had signiﬁ cantly lower Physical and Mental Component Summary scores (37.3 and 
50.9, respectively) than T2DM-only respondents (45.8 and 53.5, respectively, P < 
0.0001). Mean PHQ-9 scores were signiﬁ cantly higher among T2DM respondents with 
comorbid HTN and obesity (5.0 vs. 2.5, P < 0.0001), indicating greater depression 
burden. Approximately 16.5% of respondents with T2DM, HTN and obesity had 
moderate to severe depression (PHQ-9 scores ≥15), compared with 6.1% of respondents 
with T2DM only (P < 0.0001). CONCLUSIONS: SHIELD respondents with T2DM, 
HTN and obesity report a lower quality of both physical and mental health and more 
depression symptoms than the T2DM-only group. More research is needed to determine 
whether the poor quality of life and greater depression in this population affects self-
management of their diabetes and comorbid conditions.
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OBJECTIVES: This study aimed to investigate the health-related quality of life 
(HRQoL) of coronary heart disease (CHD) patients and healthy subjects in Hong 
Kong. METHODS: This study was a one-year prospective cohort with two groups of 
study populations, the patient group and healthy subject group. Thirty-three eligible 
patients were recruited from Prince of Wales of Hospital. The HRQoL data using 
Short-Form 36-item Health Survey (SF-36) were collected just after percutaneous 
coronary intervention (PCI) (baseline) and one year post-PCI. Thirty-ﬁ ve healthy 
subjects who were recruited from two elderly centres and parents of School of Phar-
macy (SOP) students, were also interviewed by SF-36. This study consists of two parts. 
In the ﬁ rst part, the HRQoL data of healthy subjects were compared with patients at 
baseline and 1 year post-PCI respectively. In the second part, the improvement in 
HRQoL of PCI patients at baseline and 1 year post-PCI was compared. RESULTS: 
In the ﬁ rst part of study, healthy subjects had signiﬁ cantly (P < 0.05) higher scores in 
role-physical (79.3 ± 36.6 vs. 53.8 ± 48.1), vitality (65.1 ± 23.8 vs. 49.5 ± 33.7) and 
role-emotional (93.3 ± 15.8 vs. 72.7 ± 39.5) than the patients at baseline. Patients’ 
HRQoL returned to similar level with healthy subjects after 1 year of PCI treatment. 
In the second part of the study, patients had signiﬁ cant (P < 0.05) improvements in 
bodily pain (12.7 ± 30.3) and vitality (16.1 ± 33.1) after 1 year. CONCLUSIONS: 
This study showed that the HRQoL of CHD patients was poorer than healthy popula-
tion in Hong Kong, but returned to similar level as healthy population after 1 year of 
PCI treatment. In addition, signiﬁ cant HRQoL improvements had been seen in patients 
after 1 year of PCI, especially in bodily pain and vitality.
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OBJECTIVES: To evaluate the impact of chronic venous disease (CVD) on patients’ 
professional activity and its consequence on patients’ quality of life (QOL) in 
Romania. METHODS: A large observational, multicentre, descriptive survey in CVD 
was implemented in Romania in 2009. Impact of CVD on patients’ professional 
activities and QOL were documented based on a patient self-administered question-
naire. The CIVIQ-14 was used to assess QOL (score 0 for very good to 100 for bad 
QOL). Patient data were crossed with their general practitioner evaluations on the 
severity of the disease. RESULTS: Out of 2542 screened patients, 2294 ﬁ lled in the 
questionnaire (90.2%). Among CVD patients, 7% had had hospitalization because of 
the disease, while 7% had changed their professional activities or had lost working 
days. Number of lost working days over the previous 5 years exceeded 1 week for 
most (40% lost >1 week, 35% >1 month, 16% <1 week). Patients who lost less than 
1 working week, between 1 week and 1 month and more than 1 month due to CVD 
had a worsened QOL (respectively 28.71 ± 24.32, 31.4 ± 17.73 and 31.8 ± 16.69 
CIVIQ-14 score) QOL scores paralleled the severity of CVD, going from 15.64 ± 
14.94 in C0s patients (symptoms only, according to the CEAP) to 51.79 ± 30.43 in 
C6 (patients with ulcer). The presence of pain decreased QOL (30.49 ± 19.04). QOL 
scores associated to work absenteeism varied from 21.98 ± 15.05 to 49.49 ± 20.06 
depending on absenteeism frequency (from 1 to 3 times respectively) CONCLUSIONS: 
CVD generates an important negative professional impact in Romania with productiv-
ity losses. Quality of life impairment occurs from the ﬁ rst symptoms of CVD and it 
is correlated to the work absenteeism duration and frequency. Three times out of work 
is associated to a QOL score comparable to the one quoted between grades 4 and 5 
of the CEAP classiﬁ cation.
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OBJECTIVES: This study compared ﬁ ve methods of summarizing symptom data and 
the association of these measures with the outcome health related quality of life 
(HRQL) in patients who had experienced an acute coronary syndrome event (ACS). 
METHODS: All patients listed in an ACS registry (treated for ACS and discharged 
from a university afﬁ liated hospital) during a 3 year period were mailed a question-
naire that assessed symptom status, demographics, cardiac functional status and 
therapy, comorbidity, ACS type and HRQL (SF-8 and EQ-5D). The symptom survey 
included 24 symptoms and measured the occurrence, frequency, and distress associ-
ated with each symptom during the previous four weeks. Symptom summary measures 
included summed, averaged, and multiplicative (Symptom Product) values of each 
symptom characteristic. Bivariate correlations and multivariate regression analysis 
were used to assess the association of each symptom summary measure with HRQL, 
controlling for other patient, disease, and treatment characteristics. RESULTS: A total 
of 490 of 1217 patients (40%) responded. The mean age was 65.7 ± 11.3 years; 67.7% 
male;94.0% Caucasian;PCS-8 53.7 ± 10.5; MCS-8 49.5 ± 9.5; and EQ-5D VAS 73.6 
± 20.5. The Symptom Sum = 7.8 ± 4.9, Symptom Frequency Average = 2.5 ± 0.72, 
Symptom Distress Average = 2.2 ± 0.8, Symptom Distress Sum = 18.6 ± 14.8, and 
Symptom Product = 51.7 ± 48.3. Bivariate correlations demonstrated that the 
Symptom Sum and Symptom Product had the highest correlation (>0.54) with the 
HRQL domains, while Symptom Frequency Average was the lowest (0.24–0.33). 
The same pattern was seen with the multivariate regression model. The model adjusted 
R-square for the Symptom Sum and Symptom Product measures were higher than the 
other measures, with the Symptom Product having the highest correlation. The 
R-square values ranged for these two measures depending on the HRQL domain; PCS 
(0.38–0.44), MCS (0.33–0.35), EQ-5D (0.34–0.39). CONCLUSIONS: Researchers 
may consider using Symptom Sum or a Symptom Product measures when attempting 
to summarize the association of symptoms with HRQL in ischemic heart disease 
patients.
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OBJECTIVES: To analyze, for the ﬁ rst time in a large Spanish population of heart 
failure patients, quality of life according to NYHA class II, III or IV using generic 
and speciﬁ c quality of life questionnaires. METHODS: A descriptive analysis of a 
